Welcome to LookChem.com Sign In|Join Free

CAS

  • or

63-37-6

Post Buying Request

63-37-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

63-37-6 Usage

Description

Cytidine 5'-monophosphate, also known as 5'-CMP, is a nucleotide that is used as a monomer in RNA. 5'-CMP is a key intermediate in the preparation of several nucleotide derivatives and is widely used in food and pharmaceutical industries.

Chemical Properties

white crystalline powder

Uses

Different sources of media describe the Uses of 63-37-6 differently. You can refer to the following data:
1. A constituent of nucleic acids. It was isolated from yeast nucleic acid.
2. Cytidine 5′-monophosphate has been used in Raman spectroscopy studies.

Definition

ChEBI: A pyrimidine ribonucleoside 5'-monophosphate having cytosine as the nucleobase.

Biochem/physiol Actions

Cytidine 5′-monophosphate (CMP) is used as a substrate of uridine monophosphate (UMP)/cytidine monophosphate (CMP) kinase (EC 2.7.4.4) to form CDP which upon phosphorylation to CTP supports DNA and RNA biosynthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 63-37-6 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 6 and 3 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 63-37:
(4*6)+(3*3)+(2*3)+(1*7)=46
46 % 10 = 6
So 63-37-6 is a valid CAS Registry Number.

63-37-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C1675)  Cytidine 5'-Monophosphate  >98.0%(HPLC)

  • 63-37-6

  • 1g

  • 290.00CNY

  • Detail
  • TCI America

  • (C1675)  Cytidine 5'-Monophosphate  >98.0%(HPLC)

  • 63-37-6

  • 5g

  • 990.00CNY

  • Detail
  • USP

  • (1162126)  5′-Cytidylic acid  United States Pharmacopeia (USP) Reference Standard

  • 63-37-6

  • 1162126-500MG

  • 4,326.66CNY

  • Detail

63-37-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3'-CMP

1.2 Other means of identification

Product number -
Other names 5‘-Cytidylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:63-37-6 SDS

63-37-6Synthetic route

CYTIDINE
65-46-3

CYTIDINE

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
Stage #1: CYTIDINE With trichlorophosphate at 20℃; for 0.1h; Flow reactor; Green chemistry;
Stage #2: With water at 20℃; Temperature; Flow reactor; Green chemistry; chemoselective reaction;
94%
With tris(p-nitrophenyl)phosphate at 50℃; Erwina herbicola 47/3 cells;84%
With triethyl phosphate; trichlorophosphate In water at 0℃; for 5h; Rate constant; Product distribution; var. reaction conditions;83 % Chromat.
cytidine-5'-phosphoro-(2-aminoimidazole)
69673-09-2

cytidine-5'-phosphoro-(2-aminoimidazole)

A

cytidine monophosphate
63-37-6

cytidine monophosphate

B

cytidine 5'-fluorophosphate
68521-86-8

cytidine 5'-fluorophosphate

Conditions
ConditionsYield
With water; lithium fluoride at 25℃; pH=8.6; Reagent/catalyst; pH-value;A 14.2%
B 85.4%
dibenzyl phosphochloridate
538-37-4

dibenzyl phosphochloridate

2',3'-O-isopropylidenecytidine
362-42-5

2',3'-O-isopropylidenecytidine

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
With pyridine Hydrierung des Reaktionsprodukts an Palladium in wss.Aethanol und anschliessend Hydrolyse mit wss.H2SO4;
2',3'-O-isopropylidenecytidine
362-42-5

2',3'-O-isopropylidenecytidine

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
With phosphoric acid; water; phosphorus pentoxide und anschliessend mit H2O;
Multi-step reaction with 2 steps
1: H3PO4; N-butylimidazole; Bu3N / dimethylformamide; various solvent(s) / 6 h / Heating
2: DOWEX(R) 50WX2-200
View Scheme
Multi-step reaction with 3 steps
1: 91 percent / t-butylmagnesium chloride / tetrahydrofuran / 1 h / Ambient temperature
2: Pd(P(C6H5)3)4, P(C6H5)3, HCOOH, n-C4H9NH2 / tetrahydrofuran / 5.7 h / 50 °C
3: 2 N aq. HCl / 12 h / 25 °C
View Scheme
dibenzyl phosphochloridate
538-37-4

dibenzyl phosphochloridate

O2',O3'-((R)-benzylidene)-cytidine
3257-72-5, 7558-02-3

O2',O3'-((R)-benzylidene)-cytidine

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
With pyridine Hydrierung des Reaktionsprodukts an Palladium in wss.Aethanol und anschliessend Hydrolyse mit wss.H2SO4;
O2',O3'-((R)-benzylidene)-cytidine
3257-72-5, 7558-02-3

O2',O3'-((R)-benzylidene)-cytidine

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
With phosphoric acid; water; phosphorus pentoxide und anschliessend mit H2O;
With pyridine; trichlorophosphate und Erhitzen des Reaktionsprodukts mit wss.H2SO4;
morpholine
110-91-8

morpholine

cytidine-5'-phosphodichloride
30784-94-2

cytidine-5'-phosphodichloride

A

cytidine-5'-phosphodimorpholide
122450-01-5

cytidine-5'-phosphodimorpholide

B

cytidine monophosphate
63-37-6

cytidine monophosphate

C

cytidine 5'-monophosphate morpholidate
76742-17-1

cytidine 5'-monophosphate morpholidate

Conditions
ConditionsYield
With water 1.) triethyl phosphate, 5-7 deg C, 60 min, 2.) 5-7 deg C, 7 h; Yield given. Multistep reaction. Yields of byproduct given;
With water 1.) triethyl phosphate, 5-7 deg C, 120 min, 2.) methanol, 5-7 deg C, 7 h; Yield given. Multistep reaction. Yields of byproduct given;
With water 1.) triethyl phosphate, 5-7 deg C, 10 min, 2.) methanol, 5-7 deg C, 7 h; Yield given. Multistep reaction. Yields of byproduct given;
cytidine-5'-phosphoro-(2-aminoimidazole)
69673-09-2

cytidine-5'-phosphoro-(2-aminoimidazole)

A

cytidine monophosphate
63-37-6

cytidine monophosphate

B

cytidine diphosphate
63-38-7

cytidine diphosphate

Conditions
ConditionsYield
With phosphate buffer; sodium chloride at 37℃; Rate constant; Product distribution; Mechanism;
1-methyl-4-carboxypyridinium chloride
5746-18-9

1-methyl-4-carboxypyridinium chloride

C9H15N3O8P
160984-91-8

C9H15N3O8P

A

C7H8NO2
36455-39-7

C7H8NO2

B

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
In water at 20℃; Rate constant; Equilibrium constant; pH 8.5-8.7;
terephthalaldehyde,
623-27-8

terephthalaldehyde,

C9H15N3O8P
160984-91-8

C9H15N3O8P

A

cytidine monophosphate
63-37-6

cytidine monophosphate

B

Benzene-1,4-dicarbaldehyde
623-27-8

Benzene-1,4-dicarbaldehyde

Conditions
ConditionsYield
In water at 20℃; Rate constant; pH 8.5-8.7;
cytidine-5'-phosphodichloride
30784-94-2

cytidine-5'-phosphodichloride

choline phosphate calcium salt

choline phosphate calcium salt

A

citicoline
987-78-0

citicoline

B

cytidine-5'-phosphodimorpholide
122450-01-5

cytidine-5'-phosphodimorpholide

C

cytidine monophosphate
63-37-6

cytidine monophosphate

D

cytidine 5'-monophosphate morpholidate
76742-17-1

cytidine 5'-monophosphate morpholidate

Conditions
ConditionsYield
Yield given. Multistep reaction. Yields of byproduct given;
cytidine-5'-(2-methylimidazol-1-yl phosphate)
85179-51-7

cytidine-5'-(2-methylimidazol-1-yl phosphate)

A

cytidine monophosphate
63-37-6

cytidine monophosphate

B

cytidine diphosphate
63-38-7

cytidine diphosphate

Conditions
ConditionsYield
With phosphate buffer; sodium chloride at 37℃; Rate constant; Product distribution; Mechanism;
Phosphoric acid mono-[(3aR,4R,6R,6aR)-6-(4-amino-2-oxo-2H-pyrimidin-1-yl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl] ester
149759-93-3

Phosphoric acid mono-[(3aR,4R,6R,6aR)-6-(4-amino-2-oxo-2H-pyrimidin-1-yl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl] ester

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
With hydrogenchloride at 25℃; for 12h; Yield given;
With DOWEX(R) 50WX2-200
C49H62N20O31P4

C49H62N20O31P4

A

cytidine monophosphate
63-37-6

cytidine monophosphate

C

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

D

5'-guanosine monophosphate
85-32-5

5'-guanosine monophosphate

Conditions
ConditionsYield
venom phosphodiesterase Product distribution;
Phosphoric acid mono-[(2R,3R,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-tetrahydro-furan-2-ylmethyl] ester

Phosphoric acid mono-[(2R,3R,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-tetrahydro-furan-2-ylmethyl] ester

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran for 2h; Yield given;

A

B

C

D

E

A

B

guanosine 5'-monophosphate

guanosine 5'-monophosphate

C

adenosine
58-61-7

adenosine

3',5'-cyclic cytidine monophosphate
3616-08-8

3',5'-cyclic cytidine monophosphate

A

cytidine 3'-monophosphate
84-52-6

cytidine 3'-monophosphate

B

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
Lactuca phosphodiesterase In water for 0.416667h; Product distribution; Tris-HCl buffer (pH 6.5); effect of purification stage of phosphodiesterase; relative rate of hydrolysis;
3',5'-cyclic cytidine monophosphate
3616-08-8

3',5'-cyclic cytidine monophosphate

A

cytidine 3'-monophosphate
84-52-6

cytidine 3'-monophosphate

B

cytidine monophosphate
63-37-6

cytidine monophosphate

C

cytidine-2'-monophosphate
85-94-9

cytidine-2'-monophosphate

Conditions
ConditionsYield
With hydrogenchloride at 90.1℃; Rate constant;
sodium cytidine 5'-S-methyl phosphorothiolate

sodium cytidine 5'-S-methyl phosphorothiolate

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
With iodine; potassium iodide In water at 30℃; for 0.0833333h;
With dihydrogen peroxide In water at 30℃; for 24h; Product distribution; other demethylthiolating agent;
A(2'p5'G)3'p5'C

A(2'p5'G)3'p5'C

A

cytidine monophosphate
63-37-6

cytidine monophosphate

B

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

C

5'-guanosine monophosphate
85-32-5

5'-guanosine monophosphate

Conditions
ConditionsYield
With SVP (1 unit) In water at 37℃; for 12h; Product distribution; HPLC analysis; no reaction with RNaseT2 or spleen phosphodiesterase;
A(2'p5'A)3'p5'C

A(2'p5'A)3'p5'C

A

cytidine monophosphate
63-37-6

cytidine monophosphate

B

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

Conditions
ConditionsYield
With SVP (1 unit) In water at 37℃; for 12h; Product distribution; HPLC analysis; no reaction with RNaseT2 or spleen phosphodiesterase;
cytidine-5'-monophosphono-N-acetylneuraminic acid
3063-71-6

cytidine-5'-monophosphono-N-acetylneuraminic acid

C

cytidine monophosphate
63-37-6

cytidine monophosphate

D

(2S,4S,5R,6R)-5-Acetylamino-2-azido-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxy-propyl)-tetrahydro-pyran-2-carboxylic acid

(2S,4S,5R,6R)-5-Acetylamino-2-azido-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxy-propyl)-tetrahydro-pyran-2-carboxylic acid

E

(2R,4S,5R,6R)-5-Acetylamino-2-azido-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxy-propyl)-tetrahydro-pyran-2-carboxylic acid

(2R,4S,5R,6R)-5-Acetylamino-2-azido-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxy-propyl)-tetrahydro-pyran-2-carboxylic acid

Conditions
ConditionsYield
With sodium azide; acetate buffer at 37℃; Rate constant; Product distribution; Mechanism; also in D2O and in absence of azide; also in the presence of MeOH; solvent deuterium kinetic isotope effect;
C48H72N4O4(4+)*C9H14N3O8P*4Cl(1-)

C48H72N4O4(4+)*C9H14N3O8P*4Cl(1-)

A

cytidine monophosphate
63-37-6

cytidine monophosphate

B

5,11,17,23-tetramethoxy-25,26,27,28-tetrakis(trimethylammoniomethyl)calix<4>arene tetrachloride
139934-97-7

5,11,17,23-tetramethoxy-25,26,27,28-tetrakis(trimethylammoniomethyl)calix<4>arene tetrachloride

Conditions
ConditionsYield
In water-d2 at 24.85℃; Equilibrium constant; Thermodynamic data; decomplexation;
C56H88N4O4(4+)*C9H14N3O8P*4Cl(1-)

C56H88N4O4(4+)*C9H14N3O8P*4Cl(1-)

A

cytidine monophosphate
63-37-6

cytidine monophosphate

B

5,11,17,23-tetrakis(trimethylammoniomethyl)-25,26,27,28-tetrapropoxycalix<4>arene tetrachloride

5,11,17,23-tetrakis(trimethylammoniomethyl)-25,26,27,28-tetrapropoxycalix<4>arene tetrachloride

Conditions
ConditionsYield
In water-d2 at 24.85℃; Equilibrium constant; Thermodynamic data; decomplexation;
2-phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol

2-phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol

A

cytidine monophosphate
63-37-6

cytidine monophosphate

B

2C-methyl-D-erythritol 2,4-O-cyclodiphosphate
151435-51-7

2C-methyl-D-erythritol 2,4-O-cyclodiphosphate

Conditions
ConditionsYield
With 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase; magnesium chloride In various solvent(s) at 37℃; for 2h; pH=8.0; Elimination; cyclization;A n/a
B 1.4 mg
<32P><5'>cytidylic acid

<32P><5'>cytidylic acid

cytidine monophosphate
63-37-6

cytidine monophosphate

yeast-ribonucleic acid

yeast-ribonucleic acid

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
With several enzyme systems
Phosphoric acid mono-[(3aS,4R,6R,6aR)-6-(4-amino-2-oxo-2H-pyrimidin-1-yl)-2-hydroxy-tetrahydro-furo[3,4-d][1,3,2]dioxaborol-4-ylmethyl] ester

Phosphoric acid mono-[(3aS,4R,6R,6aR)-6-(4-amino-2-oxo-2H-pyrimidin-1-yl)-2-hydroxy-tetrahydro-furo[3,4-d][1,3,2]dioxaborol-4-ylmethyl] ester

cytidine monophosphate
63-37-6

cytidine monophosphate

Conditions
ConditionsYield
With boric acid; triethylamine In water; acetonitrile pH=10.3; Equilibrium constant;
cytidine monophosphate
63-37-6

cytidine monophosphate

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

O2',O3'-carbonyl-O5'-(hydroxy-imidazol-1-yl-phosphinoyl)-cytidine
65062-74-0

O2',O3'-carbonyl-O5'-(hydroxy-imidazol-1-yl-phosphinoyl)-cytidine

Conditions
ConditionsYield
In acetonitrile for 1h; Milling;100%
2-methylimidazole
693-98-1

2-methylimidazole

cytidine monophosphate
63-37-6

cytidine monophosphate

cytidine 5'-[sodium (2-methyl-1H-imidazol-1-yl)phosphonate]

cytidine 5'-[sodium (2-methyl-1H-imidazol-1-yl)phosphonate]

Conditions
ConditionsYield
With 2,2'-Bipyridyl disulfide; triethylamine; triphenylphosphine In dimethyl sulfoxide; N,N-dimethyl-formamide for 2h; Ambient temperature;95%
Stage #1: 2-methylimidazole; cytidine monophosphate With 2,2'-dipyridyldisulphide; triethylamine; triphenylphosphine In dimethyl sulfoxide at 22℃; for 1h; Inert atmosphere;
Stage #2: With sodium perchlorate; triethylamine In diethyl ether; acetone Inert atmosphere; Cooling with ice;
With 5,15,10,20-tetraphenylporphyrin; triethylamine In dimethyl sulfoxide at 20℃; for 2.5h;
cytidine monophosphate
63-37-6

cytidine monophosphate

2-morpholino-2-oxo-1,3,2λ5-dioxaphospholane
7114-70-7

2-morpholino-2-oxo-1,3,2λ5-dioxaphospholane

C11H17N3O11P2

C11H17N3O11P2

Conditions
ConditionsYield
In methanol at 20℃; for 10h;95%
phosphorylcholine chloride
107-73-3

phosphorylcholine chloride

cytidine monophosphate
63-37-6

cytidine monophosphate

cytidine 5'-diphosphocholine sodium salt
33818-15-4

cytidine 5'-diphosphocholine sodium salt

Conditions
ConditionsYield
Stage #1: phosphorylcholine chloride; cytidine monophosphate With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide In acetonitrile at 30℃; for 5.75h; Reflux;
Stage #2: With sodium hydrogencarbonate In ethanol at 10 - 40℃; for 1h; pH=7; Temperature; Reagent/catalyst; pH-value;
92.54%
1H-imidazole
288-32-4

1H-imidazole

cytidine monophosphate
63-37-6

cytidine monophosphate

cytidine 5’-monophosphate imidazolide
1379659-43-4

cytidine 5’-monophosphate imidazolide

Conditions
ConditionsYield
Stage #1: 1H-imidazole; cytidine monophosphate With 2,2'-dipyridyldisulphide; triethylamine; triphenylphosphine In dimethyl sulfoxide; N,N-dimethyl-formamide for 3h;
Stage #2: With sodium perchlorate; triethylamine In diethyl ether; dimethyl sulfoxide; N,N-dimethyl-formamide; acetone for 2h;
85%
N-Acetylimidazole
2466-76-4

N-Acetylimidazole

cytidine monophosphate
63-37-6

cytidine monophosphate

2′,3′-di-O-acetyl-β-cytidine-5′-phosphate

2′,3′-di-O-acetyl-β-cytidine-5′-phosphate

Conditions
ConditionsYield
With sodium hydroxide In water at 20℃; for 4h; pH=8;85%
triethylamine carbonate
15715-58-9

triethylamine carbonate

cytidine monophosphate
63-37-6

cytidine monophosphate

ethylenediamine
107-15-3

ethylenediamine

2C6H15N*C11H19N4O8P

2C6H15N*C11H19N4O8P

Conditions
ConditionsYield
Stage #1: cytidine monophosphate; ethylenediamine With sodium hydrogen sulfate; 4-morpholineethanesulfonic acid; hydroquinone; sodium hydroxide In water at 20℃; for 24h; pH=6.2;
Stage #2: triethylamine carbonate In water pH=7.5;
76%
cytidine monophosphate
63-37-6

cytidine monophosphate

C9H15N3O10P2
120138-95-6

C9H15N3O10P2

Conditions
ConditionsYield
With sodium hypophosphate at 60℃; pH 6;73%
cytidine monophosphate
63-37-6

cytidine monophosphate

3',5'-cyclic cytidine monophosphate
3616-08-8

3',5'-cyclic cytidine monophosphate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide68%
C13H13N4O9P

C13H13N4O9P

cytidine monophosphate
63-37-6

cytidine monophosphate

P1-uridine-P2-cytidine-5’-diphosphate disodium

P1-uridine-P2-cytidine-5’-diphosphate disodium

Conditions
ConditionsYield
In acetonitrile for 2h;67%
cytidine monophosphate
63-37-6

cytidine monophosphate

cytidine 5'-monophosphate 2',3'-dialdehyde
63413-46-7

cytidine 5'-monophosphate 2',3'-dialdehyde

Conditions
ConditionsYield
With sodium iodate In water for 0.333333h;65.7%
(C2H5)2SnCl2(phenanthroline)

(C2H5)2SnCl2(phenanthroline)

cytidine monophosphate
63-37-6

cytidine monophosphate

Et2Sn(1,10-phenanthroline)(cytidine 5'-monophosphate)

Et2Sn(1,10-phenanthroline)(cytidine 5'-monophosphate)

Conditions
ConditionsYield
With sodium hydroxide In water byproducts: HCl; stirring (room temp., 12 h), pH = 6.0 (NaOH, stirring, 48 h); filtration, concn. (low pressure, 50 - 60°C), filtration, washing(ice H2O, MeOH, dry ether), drying (over P2O5, vac.); elem. anal.;64.5%
cytidine monophosphate
63-37-6

cytidine monophosphate

cytidine 5'-fluorophosphate
68521-86-8

cytidine 5'-fluorophosphate

Conditions
ConditionsYield
With tributyl-amine; 4 A molecular sieve; 2,4-Dinitrofluorobenzene In N,N-dimethyl-formamide for 48h; Ambient temperature;54.6%
With potassium fluoride; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In water
cytidine monophosphate
63-37-6

cytidine monophosphate

5-chlorocytidine monophosphate
47221-58-9

5-chlorocytidine monophosphate

Conditions
ConditionsYield
With ammonium nitrate; N-chloro-succinimide In acetic acid at 40℃; for 10h;54%
cytidine monophosphate
63-37-6

cytidine monophosphate

ethyl iodide
75-03-6

ethyl iodide

A

3'-O-Ethylcytidine-5'-monophosphate
50270-91-2

3'-O-Ethylcytidine-5'-monophosphate

B

2'-O-Ethylcytidine-5'-monophosphate disodium salt
145249-92-9

2'-O-Ethylcytidine-5'-monophosphate disodium salt

C

O2',O3'-diethyl-[5']cytidylic acid
50270-90-1

O2',O3'-diethyl-[5']cytidylic acid

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane for 3h; Ambient temperature;A 5.7%
B 51.7%
C 21.1%
With sodium hydroxide In 1,4-dioxane for 3h; Ambient temperature;A 5.7%
B 51.7%
C 21.1%
pyridine-2-carbaldehyde thiosemicarbazone
3608-75-1

pyridine-2-carbaldehyde thiosemicarbazone

copper(II) perchlorate hexahydrate

copper(II) perchlorate hexahydrate

cytidine monophosphate
63-37-6

cytidine monophosphate

2C7H7N4S(1-)*H2O*2Cu(2+)*ClO4(1-)*C9H13N3O8P(1-)

2C7H7N4S(1-)*H2O*2Cu(2+)*ClO4(1-)*C9H13N3O8P(1-)

Conditions
ConditionsYield
Stage #1: pyridine-2-carbaldehyde thiosemicarbazone; copper(II) perchlorate hexahydrate In water for 0.5h;
Stage #2: cytidine monophosphate With sodium hydroxide In water for 1h; pH=6;
51%
2-hydroxyethylphosphonate

2-hydroxyethylphosphonate

cytidine monophosphate
63-37-6

cytidine monophosphate

C11H17N3O11P2(2-)

C11H17N3O11P2(2-)

Conditions
ConditionsYield
Stage #1: cytidine monophosphate With triethylamine; 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide at 20℃;
Stage #2: 2-hydroxyethylphosphonate In N,N-dimethyl-formamide at 20℃; for 48h;
51%
cytidine monophosphate
63-37-6

cytidine monophosphate

cytidine triphosphate
65-47-4

cytidine triphosphate

Conditions
ConditionsYield
enzymatic synthesis (adenylate kinase, pyruvate kinase);50%
With adenylate kinase in ammonium sulfate; potassium salt of phosphophenolpyruvate; 2-hydroxyethanethiol Ambient temperature; pH 8.5; Yield given;
With inorganic polyphosphate; tris hydrochloride; magnesium chloride; CMP kinase In various solvent(s) at 37℃; pH=8.0; Product distribution; Further Variations:; reaction times; Enzymatic reaction;
With hydrogenchloride; ethylenediaminetetraacetic acid; piruvate kinase; T5 bacteriophage deoxynucleoside monophosphate kinase; potassium chloride; ATP; NADH; magnesium chloride; lactate dehydrogenase at 25℃; pH=7.5; Kinetics; Tris-HCl buffer; Enzymatic reaction;
cytidine monophosphate
63-37-6

cytidine monophosphate

5-bromocytidine-5'-monophosphate
4181-56-0

5-bromocytidine-5'-monophosphate

Conditions
ConditionsYield
With ammonium nitrate; N-Bromosuccinimide In acetic acid at 40℃; for 10h;50%
cytidine monophosphate
63-37-6

cytidine monophosphate

phenylacetaldehyde dimethyl acetal
101-48-4

phenylacetaldehyde dimethyl acetal

sodium ((3aS,4R,6R,6aS)-6-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-benzyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyldihydrogen phosphate

sodium ((3aS,4R,6R,6aS)-6-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-benzyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyldihydrogen phosphate

Conditions
ConditionsYield
In formic acid at 20℃;49%
2-hydroxypropylphosphonate

2-hydroxypropylphosphonate

cytidine monophosphate
63-37-6

cytidine monophosphate

C12H19N3O11P2(2-)

C12H19N3O11P2(2-)

Conditions
ConditionsYield
Stage #1: cytidine monophosphate With triethylamine; 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide at 20℃;
Stage #2: 2-hydroxypropylphosphonate In N,N-dimethyl-formamide at 20℃; for 48h;
40%
cytidine monophosphate
63-37-6

cytidine monophosphate

methyl iodide
74-88-4

methyl iodide

A

2',3'-Di-O-methylcytidine 5'-monophosphate
51785-60-5

2',3'-Di-O-methylcytidine 5'-monophosphate

B

3'-O-Methylcytidine 5'-monophosphate disodium salt
145249-91-8

3'-O-Methylcytidine 5'-monophosphate disodium salt

C

N3-Methylcytidine 5'-monophosphate
35470-27-0

N3-Methylcytidine 5'-monophosphate

D

2′-O-methylcytidine-5′-phosphate
18422-43-0

2′-O-methylcytidine-5′-phosphate

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane for 3h; Ambient temperature; other alkyl iodides;A 19.1%
B 11.5%
C 18.8%
D 38.3%
With sodium hydroxide In 1,4-dioxane for 3h; Ambient temperature;A 19.1%
B 11.5%
C 18.8%
D 38.3%
cytidine monophosphate
63-37-6

cytidine monophosphate

1-iodo-propane
107-08-4

1-iodo-propane

A

2-O-n-Propylcytidine-5'-monophosphate monosodium salt
145249-95-2

2-O-n-Propylcytidine-5'-monophosphate monosodium salt

B

2,3-Di-O-n-propylcytidine-5'-monophosphate monosodium salt
145249-94-1

2,3-Di-O-n-propylcytidine-5'-monophosphate monosodium salt

C

N3,2'-O-Di-n-propylcytidine-5'-monophosphate monosodium salt
145249-93-0

N3,2'-O-Di-n-propylcytidine-5'-monophosphate monosodium salt

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane at 70℃; for 3h;A 38.1%
B 13.7%
C 7.6%
cytidine monophosphate
63-37-6

cytidine monophosphate

(7-diethylaminocoumarin-4-yl)methyl phosphate
402789-43-9

(7-diethylaminocoumarin-4-yl)methyl phosphate

P2-(7-diethylaminocoumarin-4-yl)methyl cytidine 5'-diphosphate

P2-(7-diethylaminocoumarin-4-yl)methyl cytidine 5'-diphosphate

Conditions
ConditionsYield
Stage #1: cytidine monophosphate With Tri-n-octylamine In toluene at 100℃;
Stage #2: With 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide at 20℃;
Stage #3: (7-diethylaminocoumarin-4-yl)methyl phosphate In N,N-dimethyl-formamide at 20℃; for 264h;
34%
cytidine monophosphate
63-37-6

cytidine monophosphate

A

cytidine diphosphate
63-38-7

cytidine diphosphate

B

cytidine triphosphate
65-47-4

cytidine triphosphate

Conditions
ConditionsYield
With phosphorotriimidazolide; magnesium chloride at 22℃; for 72h; N-ethylmorpholine buffer (pH 7.0);A 25%
B 33%
cytidine monophosphate
63-37-6

cytidine monophosphate

mitomycin C
50-07-7

mitomycin C

2,7-diaminomitosene 1-cytidilate
132019-17-1

2,7-diaminomitosene 1-cytidilate

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 0.5h; Heating;27%
copper(II) perchlorate hexahydrate

copper(II) perchlorate hexahydrate

pyridine-2-formaldehyde N4-methyl thiosemicarbazone
6839-88-9

pyridine-2-formaldehyde N4-methyl thiosemicarbazone

cytidine monophosphate
63-37-6

cytidine monophosphate

2C8H9N4S(1-)*4H2O*2Cu(2+)*ClO4(1-)*C9H13N3O8P(1-)

2C8H9N4S(1-)*4H2O*2Cu(2+)*ClO4(1-)*C9H13N3O8P(1-)

Conditions
ConditionsYield
Stage #1: copper(II) perchlorate hexahydrate; pyridine-2-formaldehyde N4-methyl thiosemicarbazone In water for 0.5h;
Stage #2: cytidine monophosphate With sodium hydroxide In water for 1h; pH=6;
18%
Conditions
ConditionsYield
enzymatic synthesis (cytidine 5'-monophosphosialate synthase, inorganic pyrophosphatase);15.2%
With phosphoenolpyruvic acid Ambient temperature; ATP, pyruvate kinase, myokinase, inorganic phosphatase, N-acetylneuraminic acid aldolase, CMP-sialic acid synthetase HEPES buffer, pH 7.5;

63-37-6Relevant articles and documents

Cell- And Polymerase-Selective Metabolic Labeling of Cellular RNA with 2′-Azidocytidine

Wang, Danyang,Zhang, Yu,Kleiner, Ralph E.

supporting information, p. 14417 - 14421 (2020/10/13)

Metabolic labeling of cellular RNA is a powerful approach to investigate RNA biology. In addition to revealing whole transcriptome dynamics, targeted labeling strategies can be used to study individual RNA subpopulations within complex systems. Here, we describe a strategy for cell- and polymerase-selective RNA labeling with 2′-azidocytidine (2′-AzCyd), a modified nucleoside amenable to bioorthogonal labeling with SPAAC chemistry. In contrast to 2′-OH-containing pyrimidine ribonucleosides, which rely upon uridine-cytidine kinase 2 (UCK2) for activation, 2′-AzCyd is phosphorylated by deoxycytidine kinase (dCK), and we find that expression of dCK mediates cell-selective 2′-AzCyd labeling. Further, 2′-AzCyd is primarily incorporated into rRNA and displays low cytotoxicity and high labeling efficiency. We apply our system to analyze the turnover of rRNA during ribophagy induced by oxidative stress or mTOR inhibition to show that 28S and 18S rRNAs undergo accelerated degradation. Taken together, our work provides a general approach for studying dynamic RNA behavior with cell and polymerase specificity and reveals fundamental insights into nucleotide and nucleic acid metabolism.

PDE7A1 hydrolyzes cCMP

Monzel, Maike,Kuhn, Maike,B?hre, Heike,Seifert, Roland,Schneider, Erich H.

, p. 3469 - 3474 (2015/03/31)

The degradation and biological role of the cyclic pyrimidine nucleotide cCMP is largely elusive. We investigated nucleoside 3′,5′-cyclic monophosphate (cNMP) specificity of six different recombinant phosphodiesterases (PDEs) by using a highly-sensitive HPLC-MS/MS detection method. PDE7A1 was the only enzyme that hydrolyzed significant amounts of cCMP. Enzyme kinetic studies using purified GST-tagged truncated PDE7A1 revealed a cCMP KM value of 135 ± 19 μM. The Vmax for cCMP hydrolysis reached 745 ± 27 nmol/(min mg), which is about 6-fold higher than the corresponding velocity for adenosine 3′,5′-cyclic monophosphate (cAMP) degradation. In summary, PDE7A is a high-speed and low-affinity PDE for cCMP.

Immobilized Drosophila melanogaster deoxyribonucleoside kinase (DmdNK) as a high performing biocatalyst for the synthesis of purine arabinonucleotides

Serra, Immacolata,Conti, Silvia,Piskur, Jure,Clausen, Anders R.,Munch-Petersen, Birgitte,Terreni, Marco,Ubiali, Daniela

, p. 563 - 570 (2014/05/20)

Fruit fly (Drosophila melanogaster) deoxyribonucleoside kinase (DmdNK; EC: 2.7.1.145) was characterized for its substrate specificity towards natural and non-natural nucleosides, confirming its potential in the enzymatic synthesis of modified nucleotides. DmdNK was adsorbed on a solid ion exchange support (bearing primary amino groups) achieving an expressed activity >98%. Upon cross-linking with aldehyde dextran, expressed activity was 30-40%. Both biocatalysts (adsorbed or cross-linked) were stable at pH 10 and room temperature for 24 h (about 70% of retained activity). The cross-linked DmdNK preparation was used for the preparative synthesis of arabinosyladenine monophosphate (araA-MP) and fludarabine monophosphate (FaraAMP). Upon optimization of the reaction conditions (50 mM ammonium acetate, substrate/ATP ratio= 1:1.25, 2 mM MgCl2, 378C, pH 8) immobilized DmdNK afforded the title nucleotides with high conversion (>90%), whereas with the soluble enzyme lower conversions were achieved (78-87%). Arabinosyladenine monophosphate was isolated in 95% yield and high purity (96.5%).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 63-37-6